Prediction scoring model for acquired acinetobacter baumannii pneumonia in hospital

Abstract

The invention discloses a prediction scoring model for acquired acinetobacter baumannii pneumonia in a hospital, and the scoring model is based on N independent risk factors, gives different scores to each independent risk factor, carries out the superposition of the scores of each independent risk factor, calculates a total score, and carries out the prediction of the acquired acinetobacter baumannii pneumonia. The prediction scoring model has good discrimination capability, is helpful for a clinician to decide initial empirical antibacterial treatment and implement specific intervention measures, increases the probability that a patient accepts early proper empirical antibacterial treatment, reduces the case fatality rate of the patient, and improves the clinical experience of the clinician. The prognosis is improved.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a prediction scoring model for hospital-acquired Acinetobacter baumannii pneumonia. Background technique [0002] For patients with severe HAP, it is a great challenge for physicians to formulate the most appropriate empiric antimicrobial therapy for patients before positive bacterial culture results, due to severe antimicrobial resistance, the treatment options are very limited, and the prognosis is often poor ; carbapenem antibiotics are considered to be the first choice and one of the commonly used drugs for the treatment of severe HAP. However, several large-scale epidemiological surveys in China have shown that the most common pathogenic bacteria of HAP is mainly Acinetobacter baumannii, while Acinetobacter baumannii is highly resistant to carbapenems. In 2018, CHINET National Bacterial Resistance Surveillance Network showed that the national level of CR-ABA was 56.1%. ...

AI Technical Summary

Problems solved by technology

[0002] For patients with severe HAP, it is a great challenge for physicians to formulate the most appropriate empiric antimicrobial therapy for patients before positive bacterial culture results, due to severe antimicrobial resistance, the treatment options are very limited, and the prognosis is often poor ; carbapenem antibiotics are considered to be the first choice and one of the commonly used drugs for the treatment of severe HAP. However, several large-scale epidemiological surveys in China have shown that the most common pathogenic bacteria of HAP is mainly Acinetobacter baumannii, while Acinetobacter baumannii is highly resistant to carbapenems. According to the 2018 CHINET National Bacterial Resistance Surveillance Network, the national level of CR-ABA is 56.1%.

Images